T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4
C.H. Coles, Catriona McMurran, Angharad Lloyd, M. Benjamin Hock, Linda Hibbert, Marine C. C. Raman, Conor Hayes, Patrick J. Lupardus, David K. Cole, Stephen Harper
Abstract
T cell-mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leukocyte antigen (pHLA) complexes and is essential for immunosurveillance and disease control. This interaction is generally stabilized by interactions between the HLA surface and TCR germline-encoded complementarity-determining region (CDR) loops 1 and 2, whereas peptide selectivity is guided by direct interactions with the TCR CDR3 loops. Here, we solved the structure of a newly identified TCR in complex with a clinically relevant peptide derived from the cancer testis antigen melanoma antigen-A4 (MAGE-A4). The TCR bound pHLA in a position shifted toward the peptide's N terminus. This enabled the TCR to achieve peptide selectivity via an indirect mechanism, whereby the TCR sensed the first residue of the peptide through HLA residue Trp-167, which acted as a tunable gateway. Amino acid substitutions at peptide position 1 predicted to alter the HLA Trp-167 side-chain conformation abrogated TCR binding, indicating that this indirect binding mechanism is essential for peptide recognition. These findings extend our understanding of the molecular rules that underpin antigen recognition by TCRs and have important implications for the development of TCR-based therapies. T cell-mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leukocyte antigen (pHLA) complexes and is essential for immunosurveillance and disease control. This interaction is generally stabilized by interactions between the HLA surface and TCR germline-encoded complementarity-determining region (CDR) loops 1 and 2, whereas peptide selectivity is guided by direct interactions with the TCR CDR3 loops. Here, we solved the structure of a newly identified TCR in complex with a clinically relevant peptide derived from the cancer testis antigen melanoma antigen-A4 (MAGE-A4). The TCR bound pHLA in a position shifted toward the peptide's N terminus. This enabled the TCR to achieve peptide selectivity via an indirect mechanism, whereby the TCR sensed the first residue of the peptide through HLA residue Trp-167, which acted as a tunable gateway. Amino acid substitutions at peptide position 1 predicted to alter the HLA Trp-167 side-chain conformation abrogated TCR binding, indicating that this indirect binding mechanism is essential for peptide recognition. These findings extend our understanding of the molecular rules that underpin antigen recognition by TCRs and have important implications for the development of TCR-based therapies. T cell–mediated immunity is essential during pathogen and cancer surveillance and plays a key role in autoimmunity and transplant rejection (1Coppieters K.T. Dotta F. Amirian N. Campbell P.D. Kay T.W.H. Atkinson M.A. Roep B.O. von Herrath M.G. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.J. Exp. Med. 2012; 209 (22213807): 51-6010.1084/jem.20111187Crossref PubMed Scopus (424) Google Scholar, 2Bulek A.M. Cole D.K. Skowera A. Dolton G. Gras S. Madura F. Fuller A. Miles J.J. Gostick E. Price D.A. Drijfhout J.W. Knight R.R. Huang G.C. Lissin N. Molloy P.E. et al.Structural basis for the killing of human beta cells by CD8+T cells in type 1 diabetes.Nat. Immunol. 2012; 13 (22245737): 283-28910.1038/ni.2206Crossref PubMed Scopus (123) Google Scholar, 3Cole D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar, 4Cole D.K. Fuller A. Dolton G. Zervoudi E. Legut M. Miles K. Blanchfield L. Madura F. Holland C.J. Bulek A.M. Bridgeman J.S. Miles J.J. Schauenburg A.J.A. Beck K. Evavold B.D. et al.Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope.Front. Immunol. 2017; 8 (29209312): 150310.3389/fimmu.2017.01503Crossref PubMed Scopus (13) Google Scholar, 5Archbold J.K. Macdonald W.A. Miles J.J. Brennan R.M. Kjer-Nielsen L. McCluskey J. Burrows S.R. Rossjohn J. Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry.J. Biol. Chem. 2006; 281 (16963442): 34324-3433210.1074/jbc.M606755200Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar). T cells can interrogate the full cellular proteome via scanning of short peptides (a product of proteasomal degradation) presented on the cell surface by human leukocyte antigens (pHLA). T cell activation is tightly controlled by the clonally expressed T cell receptor (TCR) via direct recognition of its cognate pHLA. Thus, characterizing the molecular determinants that govern TCR-pHLA interactions is important for understanding the biology that underpins antigen discrimination by T cells, with obvious implications for the development of novel therapeutics. Accordingly, many studies have focused on characterizing the nature of functional TCR-pHLA interactions, particularly the biophysical (6Cole D.K. Bulek A.M. Dolton G. Schauenberg A.J. Szomolay B. Rittase W. Trimby A. Jothikumar P. Fuller A. Skowera A. Rossjohn J. Zhu C. Miles J.J.J. Peakman M. Wooldridge L. et al.Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.J. Clin. Invest. 2016; 126 (27183389): 2191-220410.1172/JCI85679Crossref PubMed Scopus (80) Google Scholar, 7Bridgeman J.S. Sewell A.K. Miles J.J. Price D.A. Cole D.K. Structural and biophysical determinants of αβ T-cell antigen recognition.Immunology. 2012; 135 (22044041): 9-1810.1111/j.1365-2567.2011.03515.xCrossref PubMed Scopus (80) Google Scholar, 8Aleksic M. Liddy N. Molloy P.E. Pumphrey N. Vuidepot A. Chang K.-M. Jakobsen B.K. Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.Eur. J. Immunol. 2012; 42 (22949370): 3174-317910.1002/eji.201242606Crossref PubMed Scopus (163) Google Scholar, 9van der Merwe P.A. Davis S.J. Molecular interactions mediating T cell antigen recognition.Annu. Rev. Immunol. 2003; 21 (12615890): 659-68410.1146/annurev.immunol.21.120601.141036Crossref PubMed Scopus (412) Google Scholar, 10Schmid D.A. Irving M.B. Posevitz V. Hebeisen M. Posevitz-Fejfar A. Sarria J.-C.F. Gomez-Eerland R. Thome M. Schumacher T.N.M. Romero P. Speiser D.E. Zoete V. Michielin O. Rufer N. Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.J. Immunol. 2010; 184 (20351194): 4936-494610.4049/jimmunol.1000173Crossref PubMed Scopus (135) Google Scholar, 11van der Merwe P.A. Dushek O. Mechanisms for T cell receptor triggering.Nat. Rev. Immunol. 2011; 11 (21127503): 47-5510.1038/nri2887Crossref PubMed Scopus (278) Google Scholar) and structural parameters (4Cole D.K. Fuller A. Dolton G. Zervoudi E. Legut M. Miles K. Blanchfield L. Madura F. Holland C.J. Bulek A.M. Bridgeman J.S. Miles J.J. Schauenburg A.J.A. Beck K. Evavold B.D. et al.Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope.Front. Immunol. 2017; 8 (29209312): 150310.3389/fimmu.2017.01503Crossref PubMed Scopus (13) Google Scholar, 12Holland C.J. MacLachlan B.J. Bianchi V. Hesketh S.J. Morgan R. Vickery O. Bulek A.M. Fuller A. Godkin A. Sewell A.K. Rizkallah P.J. Wells S. Cole D.K. In silico and structural analyses demonstrate that intrinsic protein motions guide T cell receptor complementarity determining region loop flexibility.Front. Immunol. 2018; 9 (29696015): 67410.3389/fimmu.2018.00674Crossref PubMed Scopus (17) Google Scholar, 13Armstrong K.M. Piepenbrink K.H. Baker B.M. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.Biochem. J. 2008; 415 (18800968): 183-19610.1042/BJ20080850Crossref PubMed Scopus (90) Google Scholar, 14Willcox B.E. Gao G.F. Wyer J.R. Ladbury J.E. Bell J.I. Jakobsen B.K. van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface.Immunity. 1999; 10 (10204491): 357-36510.1016/S1074-7613(00)80035-7Abstract Full Text Full Text PDF PubMed Scopus (271) Google Scholar, 15Krogsgaard M. Prado N. Adams E.J. He Davis Evidence that structural flexibility during TCR binding can to T cell 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, S. J. Baker B.M. TCR scanning of through of receptor and molecular Immunol. PubMed Scopus Google Scholar, Piepenbrink K.H. Baker B.M. of loop flexibility T-cell receptor and binding Biol. 2011; PubMed Scopus Google Scholar, Baker B.M. of binding loop flexibility in T cell receptor and 2016; PubMed Scopus Google Scholar, Baker B.M. of by molecular the of T cell receptor binding J. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, B. J. of the TCR and structural in to peptide a molecular Biol. 10 PubMed Scopus Google Scholar, A.M. flexibility and by molecular of a Biol. 2012; 8 PubMed Scopus Google Scholar) that govern T cell Structural have that peptides presented in an in by a with the HLA binding the HLA Trp-167 and the of the and of HLA that the peptide N and for peptides is primarily by the residue 1 and peptide residue which by highly P.J. M.A. B. of the human PubMed Scopus Google Scholar). peptide a for direct TCR P. of the complex between human T-cell peptide and PubMed Scopus Google Scholar). TCRs to pHLA with a the of the the TCR complementarity-determining region (CDR) loops to on the peptide and the HLA J. Gras S. Miles J.J. S.J. McCluskey J. T cell antigen receptor recognition of Rev. Immunol. PubMed Scopus Google Scholar). This the CDR3 loops to the of direct peptide whereas the germline-encoded and loops generally interactions with the HLA and D.K. Miles K.M. Madura F. Holland C.J. Schauenburg Godkin A.J. Bulek A.M. Fuller A. Liddy N. M. Rizkallah P.J. Jakobsen B.K. et receptor complex Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). TCRs of by binding toward the N of the peptide D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar, S. Burrows S.R. Kjer-Nielsen L. Bell McCluskey J. Rossjohn J. The of T cell receptor recognition by 2009; Full Text Full Text PDF PubMed Scopus Google Scholar, L. Burrows S.R. McCluskey J. Rossjohn J. structural basis for the of αβ T cell in 2003; Full Text Full Text PDF PubMed Scopus Google at D.K. S. D.A. of a human autoimmune TCR is by a TCR PubMed Scopus Google Scholar, M. J. of complex binding by a human autoimmune T cell Immunol. PubMed Scopus Google in F. van der J. G. S. A. McCluskey J. et cell receptor recognition of a Immunol. PubMed Scopus Google Scholar). These binding can to of the by for the germline-encoded loops to peptide D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). recent that is the in the peptide that can TCR selectivity Kjer-Nielsen L. Miles J.J. L. Burrows S.R. McCluskey J. Rossjohn J. T cell receptor a peptide presented by a complex Immunol. 8 PubMed Scopus Google Scholar, V. Bulek A. Fuller A. A. M. Rizkallah Dolton G. Sewell Cole molecular T-cell receptor (TCR) of a human melanoma Biol. Chem. 2016; Full Text Full Text PDF PubMed Scopus Google Scholar, D.K. M. Miles J.J. K. J. Gostick E. Adams Skowera A. Peakman M. Wooldridge L. Price D.A. Sewell A.K. of peptides that alter TCR binding and T cell Immunol. 2010; PubMed Scopus Google Scholar). In this we solved the structure of a newly identified TCR in complex with an melanoma antigen-A4 peptide to as is a key is expressed by many and and melanoma M. van N. P. V. B. E. G. F. A. R. M. et in with melanoma with an peptide by and presented by J. 1999; PubMed Scopus Google Scholar, V. W. A. M. structure of in complex with a peptide by the Biol. PubMed Scopus Google Scholar). that the TCR bound in a position shifted toward the peptide N terminus. This enabled the TCR to achieve peptide selectivity for via a novel indirect mechanism whereby the TCR sensed the peptide through an HLA which acted as a tunable The side-chain conformation of this HLA residue an for the with the shifted binding to selectivity for the peptide our molecular of TCR binding to a clinically relevant epitope our understanding of the rules that underpin TCR antigen recognition. with we an TCR from T cells from The TCR identified from a of TCRs from T cells, and on its to expressed and as a in and its to to in biophysical structure of the TCR-pHLA complex solved to The structure by the TCR-pHLA The TCR bound to in a position shifted toward the peptide N terminus. TCR-pHLA interaction parameters J. Gras S. Miles J.J. S.J. McCluskey J. T cell antigen receptor recognition of Rev. Immunol. PubMed Scopus Google the TCR a of with the the and N of the the TCR the and of the and the TCR and loops the peptide and and TCR-pHLA of of in a this the TCR to many TCR-pHLA complex J. Gras S. Miles J.J. S.J. McCluskey J. T cell antigen receptor recognition of Rev. Immunol. PubMed Scopus Google with of the HLA and in to the in the peptide and and its abrogated its to direct with the HLA from the TCR with HLA and Trp-167, and peptide focused toward with the of with the TCR and These interactions in a TCR-pHLA surface of and of the with the which the for TCR-pHLA complexes J. Gras S. Miles J.J. S.J. McCluskey J. T cell antigen receptor recognition of Rev. Immunol. PubMed Scopus Google Scholar). of the V. W. A. M. structure of in complex with a peptide by the Biol. PubMed Scopus Google Scholar) and the TCR-pHLA complex of the peptide and TCR changes to from the structural the TCR-pHLA at and structural of as for TCR-pHLA interactions Kjer-Nielsen L. Miles J.J. L. Burrows S.R. McCluskey J. Rossjohn J. T cell receptor a peptide presented by a complex Immunol. 8 PubMed Scopus Google Scholar, F. Rizkallah P.J. Holland C.J. Fuller A. Bulek A. Godkin A.J. Schauenburg A.J. Cole D.K. Sewell A.K. Structural basis for T-cell to J. Immunol. PubMed Scopus (44) Google Scholar, F. Rizkallah P.J. Legut M. Holland C.J. Fuller A. Bulek A. Schauenburg A.J. Trimby A. J.R. Wells Godkin A. Miles J.J. M. Liddy N. et of peptide J. Immunol. PubMed Scopus Google Scholar). of the TCR-pHLA complex that TCR residue HLA residue Trp-167 which in peptide position an indirect between the TCR and peptide residue This indirect interaction the that the TCR to the of the peptide residue in this of the complex structure of shifted S. Burrows S.R. Kjer-Nielsen L. Bell McCluskey J. Rossjohn J. The of T cell receptor recognition by 2009; Full Text Full Text PDF PubMed Scopus Google a indirect interaction between the TCR residue and peptide residue via HLA residue Trp-167, Trp-167 shifted toward the to the peptide in this structure Thus, this is to the TCR and a TCR mechanism to peptide and achieve pHLA binding the of complexes with at peptide residue 1 and This that Trp-167 as a molecular its with to the on the of peptide residue with the first with to the position of peptides with at position Trp-167 its position to the a and at peptide position 1 a mechanism of of Trp-167, and the with and the with and and the with and These that the TCR to peptide at position direct with this peptide The TCR bound to with a of as by surface This is the binding affinity of TCRs J.S. Sewell A.K. Miles J.J. Price D.A. Cole D.K. Structural and biophysical determinants of αβ T-cell antigen recognition.Immunology. 2012; 135 (22044041): 9-1810.1111/j.1365-2567.2011.03515.xCrossref PubMed Scopus (80) Google Scholar, 8Aleksic M. Liddy N. Molloy P.E. Pumphrey N. Vuidepot A. Chang K.-M. Jakobsen B.K. Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.Eur. J. Immunol. 2012; 42 (22949370): 3174-317910.1002/eji.201242606Crossref PubMed Scopus (163) Google Scholar, D.K. Pumphrey M. Bell J.I. Gostick E. Price D.A. Gao G.F. Sewell A.K. Jakobsen B.K. affinity is governed by Immunol. PubMed Scopus Google Scholar). affinity of the TCR to a peptide a of binding this we solved the structure of at 1 and of in the TCR-pHLA complex with the that an in position 1 result in the of HLA residue Trp-167 toward TCR loop residue the indirect interaction between the TCR and the peptide through is an important therapeutic for a of Thus, we our R. Molloy P.E. Vuidepot E. S. Liddy N. J. Jakobsen B.K. of human T-cell with by PubMed Scopus Google Scholar) to an of the which in the loop and The selectivity of this TCR by its binding affinity to pHLA with peptide with the the TCR highly to changes at peptide position 1 with the the TCR bound to of the peptide with a a of the of in the TCR on the between peptide residue 1 and we an of the TCR in which TCR residue HLA residue to the a peptide the binding affinity by whereas the TCR bound with a in affinity Full of the peptide in for the a peptide the to binding, whereas for the of an and These demonstrate that TCR residue for the peptide via changes in HLA residue TCRs generally have affinity J.S. Sewell A.K. Miles J.J. Price D.A. Cole D.K. Structural and biophysical determinants of αβ T-cell antigen recognition.Immunology. 2012; 135 (22044041): 9-1810.1111/j.1365-2567.2011.03515.xCrossref PubMed Scopus (80) Google Scholar, 8Aleksic M. Liddy N. Molloy P.E. Pumphrey N. Vuidepot A. Chang K.-M. Jakobsen B.K. Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.Eur. J. Immunol. 2012; 42 (22949370): 3174-317910.1002/eji.201242606Crossref PubMed Scopus (163) Google Scholar, D.K. Pumphrey M. Bell J.I. Gostick E. Price D.A. Gao G.F. Sewell A.K. Jakobsen B.K. affinity is governed by Immunol. PubMed Scopus Google Scholar). This with the of that to T cell to the to to and TCRs R. Molloy P.E. Vuidepot E. S. Liddy N. J. Jakobsen B.K. of human T-cell with by PubMed Scopus Google Scholar) for in cellular A. Molloy A. B. R. Vuidepot A. Cole et of escape by CD8 T cells T-cell Med. 2008; PubMed Scopus Google Scholar, O. A. B. J. S. M. S. et T cells in Med. 21 PubMed Scopus Google Scholar) as T cell N. G. Adams A. J. Bianchi Pumphrey K. Gostick E. Sewell A.K. Lissin Molloy P.E. et cell Med. 2012; PubMed Scopus Google Scholar). understanding the binding selectivity of the TCR is to the development of and C.J. R.M. B. A. V. Lissin N. P.J. M. B. et of T cell and Clin. Invest. PubMed Scopus Google Scholar, B.J. J. V. Bianchi F. J.E. M. G. G. Vuidepot A. A. Adams et of a peptide as a for T Med. PubMed Scopus Google Scholar, L. L. A. B.M. P.J. Pumphrey et and of T cells in and PubMed Scopus Google Scholar, Rizkallah P.J. R. J. G. P. E. E. N. Vuidepot A. M. Cole D.K. et molecular by an affinity TCR for cancer 2016; PubMed Scopus Google Scholar). Here, we solved a structure of the TCR in complex with a relevant for with structural and biophysical a novel mechanism of selectivity whereby the loop of the TCR the of peptide residue 1 via a molecular guided by a in residue with studies and TCRs D.K. Miles K.M. Madura F. Holland C.J. Schauenburg Godkin A.J. Bulek A.M. Fuller A. Liddy N. M. Rizkallah P.J. Jakobsen B.K. et receptor complex Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, F. Rizkallah P.J. Legut M. Holland C.J. Fuller A. Bulek A. Schauenburg A.J. Trimby A. J.R. Wells Godkin A. Miles J.J. M. Liddy N. et of peptide J. Immunol. PubMed Scopus Google Scholar, D.K. M. Rizkallah P.J. Jakobsen B.K. Baker B.M. peptide govern affinity binding of a TCR a Immunol. PubMed Scopus Google Scholar, F. Rizkallah P.J. Miles K.M. Holland C.J. Bulek A.M. Fuller A. Schauenburg A.J.A. Miles J.J. Liddy N. M. M. Baker B.M. Jakobsen B.K. Sewell A.K. et receptor by Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, Rizkallah P.J. E. B. R. Gao F. M. J. Jakobsen B.K. of human T cell receptor by affinity for cognate peptide-MHC 2006; PubMed Scopus Google Scholar, M. Rizkallah P.J. S. Molloy P. R. Vuidepot A. E. P. Gao F. Jakobsen B.K. of affinity human T-cell bound to peptide complex binding PubMed Scopus Google Scholar, D.K. A. Beck K. J. Miles J.J. Bulek A.M. Dolton G. Schauenburg A.J. A. Fuller A. M. B. Rizkallah P.J. et al.Structural mechanism of a that a peptide derived from human Biol. Chem. 2017; Full Text Full Text PDF PubMed Scopus Google this binding selectivity for the TCR and an TCR that the selectivity in this by the of the findings that with the of TCR binding in which the CDR3 loops the and the germline-encoded and loops the The mechanism presented the of in determining selectivity a through that epitope to the a of TCRs the peptide via HLA residue Trp-167, in the structure of the TCR complex with an S. Burrows S.R. Kjer-Nielsen L. Bell McCluskey J. Rossjohn J. The of T cell receptor recognition by 2009; Full Text Full Text PDF PubMed Scopus Google Scholar) and in the structure of the TCR complex with an peptide J.J. Bulek A.M. Cole D.K. Gostick E. Schauenburg A.J.A. Dolton G. V. Burrows S.R. Wooldridge L. Price D.A. Rizkallah P.J. Sewell A.K. and structural basis for of a T cell receptor in virus 2010; PubMed Scopus Google the implications of this indirect peptide interaction for peptide selectivity in that the of an HIV peptide by the of for an residue R.R. E.J. The structural basis for the of peptide Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). in to interactions with Trp-167 in the binding the of binding for this TCR findings with our that Trp-167 plays a role in for a role of Trp-167 in TCR recognition in R. J. L. N. L. N. C. complex molecular structure in in antigen 2018; Google Scholar). a indirect peptide mechanism for TCRs through HLA residue Trp-167 binding that the nature of antigen recognition. In to the implications for direct on findings by and that the binding surface is we have that the of complex can to the peptide to of the C. E. Rizkallah P.J. Beck K. Trimby A. Sewell A.K. Cole D.K. of the complex binding to an Biol. Chem. Full Text Full Text PDF PubMed Scopus Google and that in peptide can have that alter the and TCR of peptide V. Bulek A. Fuller A. A. M. Rizkallah Dolton G. Sewell Cole molecular T-cell receptor (TCR) of a human melanoma Biol. Chem. 2016; Full Text Full Text PDF PubMed Scopus Google Scholar). a of studies have that flexibility in the peptide and the HLA can guide epitope to T cells M. M. G. M. M. S. is a peptide affinity of J. Immunol. 2012; 42 PubMed Scopus Google Scholar, Baker B.M. and peptide-dependent motions in implications and biophysical Immunol. 2017; 8 PubMed Scopus Google Scholar, Piepenbrink K.H. B.E. Cole D.K. Sewell A.K. Baker B.M. T cell receptor by of peptide-MHC molecular 2009; Full Text Full Text PDF PubMed Scopus Google Scholar, B.E. K. E. Baker B.M. of complex protein molecular flexibility and the implications for Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, A. C. F. Baker B.M. in peptide-dependent of flexibility.Front. Immunol. 10 PubMed Scopus Google Scholar). Here, we to findings by that HLA can as a molecular side-chain in to the of the In our demonstrate that selectivity can via indirect HLA guided by a peptide-dependent in the HLA Thus, we the HLA surface as an of the peptide in HLA conformation is the direct of the peptide These findings have implications for our understanding of pHLA protein during TCR and the mechanisms a for the of TCR-based therapeutics. cells, from an with 1 to T cells that to cells to cells with an T cells and on of the activation T cells for by with an T cells that to cells and TCR identified by of TCRs for the TCR to as R. Molloy P.E. Vuidepot E. S. Liddy N. J. Jakobsen B.K. of human T-cell with by PubMed Scopus Google Scholar). of TCRs with in the the The in the CDR3 region the affinity from to The TCR and the and expressed in the as B.E. Gao G.F. Wyer J.R. Ladbury J.E. Bell J.I. Jakobsen B.K. van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface.Immunity. 1999; 10 (10204491): 357-36510.1016/S1074-7613(00)80035-7Abstract Full Text Full Text PDF PubMed Scopus (271) Google Scholar). TCR to the and of and with an as D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). The expressed with surface a and in the of and the as D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). TCRs and a TCR D.K. Yuan F. Rizkallah P.J. Miles J.J. Gostick E. Price D.A. Gao G.F. Jakobsen B.K. Sewell A.K. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.J. Biol. Chem. 2009; 284 (19605354): 27281-2728910.1074/jbc.M109.022509Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). binding analyses a with a as D.K. Rizkallah P.J. M. Vuidepot A. M. Gao F. Bell J.I. Jakobsen B.K. Gao G.F. and structure of an affinity human CD8 PubMed Scopus Google Scholar). as a on cell and analyses at of pHLA to the The TCR at from and the of the interaction at 10 The binding and the a of protein of in a in a at in a for the TCR-pHLA complex in the 1 to of protein of a to of from an in a of the a of and at K. at at the at the at TCR-pHLA and and through the P.A. K. and 2012; PubMed Scopus Google and in the and to Molecular to and and and as in A.J. Adams P.D. PubMed Scopus Google Scholar). the as TCR-pHLA of and in E.J. of by the Biol. PubMed Scopus Google Scholar) as TCR-pHLA in P. K. for molecular Biol. PubMed Scopus Google and the E.J. of by the Biol. PubMed Scopus Google Scholar) for of the J. G. P.E. The PubMed Scopus Google Scholar). as TCR-pHLA and and Full and in TCR residue to V. C. J. G. F. E. J. L. F. G. P. the 2009; PubMed Scopus Google between and and a acid between and the and in the W. The Molecular Scholar). structural E. K. a for protein structure in Biol. PubMed Scopus Google Scholar). surface of interactions, and TCR TCR-pHLA and and structure in the with and The that the findings of this the and the A. for with and and for of and Vuidepot for and and L. for the for and the of and for with and with peptide-human leukocyte human leukocyte antigen T cell receptor complementarity-determining region melanoma antigen-A4 surface